Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Actinium Pharmaceuticals, Inc. (ATNM) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Actinium Pharmaceuticals, Inc. (ATNM), most recent 12 months reported: revenue $90K, net income $11.31M, free cash flow -$24.68M. Latest balance sheet on file: liquid cash $36.47M. From SEC filings. Others in Pharmaceutical Preparations: VYOME HOLDINGS, INC. · BULLFROG AI HOLDINGS, INC. · IBIO, INC. · ASPIRE BIOPHARMA HOLDINGS, INC. · AVALO THERAPEUTICS, INC. · SILO PHARMA, INC. · LUNAI BIOWORKS INC. · ALTIMMUNE, INC.

Stock screener

Watchlist